Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Traws Pharma (TRAW) Prepaid Assets (2016 - 2025)

Historic Prepaid Assets for Traws Pharma (TRAW) over the last 14 years, with Q3 2025 value amounting to $1.2 million.

  • Traws Pharma's Prepaid Assets fell 1278.74% to $1.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.2 million, marking a year-over-year decrease of 1278.74%. This contributed to the annual value of $1.8 million for FY2024, which is 148.27% up from last year.
  • As of Q3 2025, Traws Pharma's Prepaid Assets stood at $1.2 million, which was down 1278.74% from $966000.0 recorded in Q2 2025.
  • Over the past 5 years, Traws Pharma's Prepaid Assets peaked at $1.8 million during Q4 2024, and registered a low of $332000.0 during Q4 2021.
  • Its 5-year average for Prepaid Assets is $1.1 million, with a median of $1.1 million in 2022.
  • As far as peak fluctuations go, Traws Pharma's Prepaid Assets plummeted by 5401.66% in 2021, and later skyrocketed by 22459.89% in 2023.
  • Quarter analysis of 5 years shows Traws Pharma's Prepaid Assets stood at $332000.0 in 2021, then skyrocketed by 68.98% to $561000.0 in 2022, then soared by 224.6% to $1.8 million in 2023, then increased by 1.48% to $1.8 million in 2024, then plummeted by 34.31% to $1.2 million in 2025.
  • Its Prepaid Assets was $1.2 million in Q3 2025, compared to $966000.0 in Q2 2025 and $1.3 million in Q1 2025.